Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jian Wang
Institution:
Second Affiliated Hospital of Fujian Medical University
Observed institutions:
Nanfang Hospital,
Second Affiliated Hospital of Fujian Medical University,
Southern Medical University
ORCID:
0000-0002-8403-3832
Observed ORCID:
0000-0002-8403-3832
OpenAlex ID:
A5007076796
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2022
·
Li-Li Long
, Si-Cong Ma
, et al.
·
Cancer Research
·
45
PDF
Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases
2024
·
Jia-Run Lin
, Duan-Duan Han
, et al.
·
Cancer Research
·
11
METTL3/IGF2BP2-Mediated m6A RNA Methylation Drives Alveolar Macrophage-Dependent Neutrophil Recruitment in Cigarette Smoke-Induced COPD
2025
·
Andi Lin
, Jian Wang
, et al.
·
Journal of Inflammation Research
·
5
PDF
Figure S3 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S2 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S7 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S4 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S6 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S5 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Supplementary Table 1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Supplementary Table 2 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025
·
Li-Li Long
, Si-Cong Ma
, et al.
Supplementary Data from Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases
2024
·
Jia-Run Lin
, Duan-Duan Han
, et al.
Data from Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases
2024
·
Jia-Run Lin
, Duan-Duan Han
, et al.
Data from Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases
2024
·
Jia-Run Lin
, Duan-Duan Han
, et al.
Data from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S4 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Supplementary Table 1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S4 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S6 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S3 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S5 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Figure S2 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2023
·
Li-Li Long
, Si-Cong Ma
, et al.
Show more works
View as search
Works count:
33
Citation count:
61
H-index:
3
I10-index:
2
Year
Topic
Type